Cancer Research Yields Promising Results

Closing Gap between Research Advances and Clinical Practice Crucial to Development of European

04-Aug-2005 - Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either ...

Genencor scales back health care activities

03-Aug-2005 - As previously announced, Danisco has been working to spin off Genencor's health care activities. It has now been decided to divest the product portfolio rather than spin it off into a company with Danisco as a co-shareholder. The decision results in an immediate reduction in force in Genencor ...

Schering-Plough Appoints Paul Medeiros Vice President, Global Licensing

03-Aug-2005 - Schering-Plough Corporation announced that Paul Medeiros has been appointed vice president, Global Licensing, effective immediately. He is based in Kenilworth and reports to Michael J. DuBois, senior vice president, Global Licensing. In this role, Medeiros leads worldwide specialty product ...

GTC Biotherapeutics receives notice of allowance on purification patent

03-Aug-2005 - GTC Biotherapeutics, Inc. announced that the United States Patent and Trademark Office has issued a notice of allowance for the claims in its patent application 10/635,117 covering tangential flow filtration technology. These claims provide GTC with a unique position in the use of this technology ...

Definiens Announces Expansion to North America

03-Aug-2005 - Definiens AG announced the opening of a wholly owned U.S. subsidiary, Definiens Inc., which closely follows the company's global expansion plan. This momentous growth is also due to an increased demand for Definiens' products and solutions, as well as part of an effort to continue the high level ...

Cornell researcher uncovers details of how cancer spreads

03-Aug-2005 - Cornell University researchers have now furthered understanding of how the metabolic pathways that allow cancer to metastasize work. Their insights might aid future research on drug therapies that disrupt the sequence of events that lead to metastasis. A study published in the journal ...

Cryptome Discovers Novel Compounds to Treat Cancer

02-Aug-2005 - Cryptome Pharmaceuticals Ltd announced that it has lodged a provisional patent application on a broad class of compounds to treat cancer. The compounds have been shown to inhibit growth of cancer cells and to inhibit angiogenesis in the laboratory. They were discovered using the company's ...

454 Life Sciences Publishes Breakthrough Genome Sequencing Technique

Microfabrication Allows Sequencing in Record Time

02-Aug-2005 - 454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation , announced the publication of a new genome sequencing technique 100 times faster than previous technologies. This is the first new technology for genome sequencing to be developed and commercialized since ...

New CEO of DakoCytomation A/S

02-Aug-2005 - After six years of fruitful service Jes Østergaard is passing the mantle to Patrik Dahlén, board member at DakoCytomation since 2003 and CEO of the company BioImage A/S. Jes Østergaard will continue as a consultant for the management of DakoCytomation. "DakoCytomation has grown and has undergone ...

QIAGEN to Acquire Bioanalytical Assets from SuNyx GmbH

02-Aug-2005 - QIAGEN N.V. announced that it has entered into a definitive agreement to acquire the assets related to the bioanalytical business of SuNyx GmbH. SuNyx has developed and recently initiated marketing of its proprietary MPep and MProtChip® platforms for sample preparation of peptide and protein ...